Transoral robotic surgery (<scp>TORS</scp>) using the da Vinci Xi: prospective analysis of feasibility, safety, and outcomes
Jeroen Meulemans(KU Leuven), Vincent Vander Poorten(KU Leuven), Ann Goeleven(KU Leuven), Annouschka Laenen(Statistics Belgium), Sandra Nuyts(Cancer Institute (WIA)), Paul M. Clément(Universitair Ziekenhuis Leuven), Pierre Delaere, Margaux Vanermen(KU Leuven)
Cited by 21
Related Papers
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
|Journal of Clinical Oncology|2009|573
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
|The Lancet Oncology|2016|504